SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Clinical trial NCT01752933 · COMPLETED

Trial details

NCT number: NCT01752933
Sponsor: Astex Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2012-12-01
Primary completion: 2015-09-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.